Inventor
David Kirn
Inventor
Mill Valley, CA, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C12NMicroorganisms or enzymes25%
C07KPeptides9%
A61NElectrotherapy4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
A01KAnimal husbandry3%
C12YEnzymes1%
PatentTitleYear
11,118,192Adeno-associated virus variant capsids and methods of use thereof202110,767,166Methods and compositions for production of vaccina virus202010,434,169Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus201910,202,581Methods and compositions for production of vaccinia virus20199,919,047'Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus'20189,919,062'Oncolytic vaccinia virus cancer therapy'20189,827,278Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses20179,719,105'Methods and compositions for production of vaccinia virus'20179,226,977'Oncolytic vaccinia virus cancer therapy'20169,180,151'Oncolytic vaccinia virus combination cancer therapy'20159,180,149'Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses'20158,986,674'Methods and compositions concerning poxviruses and cancer'20158,980,246'Oncolytic vaccinia virus cancer therapy'20158,747,837'Oncolytic vaccinia virus combination cancer therapy'20148,329,164'Methods and compositions concerning poxviruses and cancer'20126,296,845'Selective killing and diagnosis of p53+ neoplastic cells'20016,133,243'Liposomal-viral DNA complexes for treating disease'20006,080,578'Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2001Patents assigned to ONYX PHARMA INC (3)· patent assignee history
2000–2020Based in Mill Valley, CA, US· patent location history
2012–2018Patents assigned to KIRN DAVID (6)· patent assignee history
2012–2015Patents assigned to JENNEREX INC (3)· patent assignee history
2014–2018Based in San Francisco, CA, US· patent location history
2015–2020Patents assigned to SILLAJEN BIOTHERAPEUTICS INC (12)· patent assignee history
2017–2018Patents assigned to BELL JOHN (2)· patent assignee history
2021Based in Emeryville, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SILLAJEN BIOTHERAPEUTICS INC | 12 | 2015–2020 |
| KIRN DAVIDself | 6 | 2012–2018 |
| JENNEREX INC | 3 | 2012–2015 |
| ONYX PHARMA INC | 3 | 2000–2001 |
| BELL JOHN | 2 | 2017–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mill Valley, California, US | 12 | 2000–2020 |
| San Francisco, California, US | 5 | 2014–2018 |
| Emeryville, California, US | 1 | 2021 |